Celldex Therapeutics Inc
F:TCE2
Celldex Therapeutics Inc
F:TCE2
Price:
36.65
EUR
3.04%
Market Closed
Market Cap:
€2.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Celldex Therapeutics Inc
F:TCE2
|
US |
|
Hennessy Capital Investment Corp VI
OTC:HCVI
|
US |
|
I
|
Illumina Inc
XMUN:ILU
|
US |
|
A
|
Avery Dennison Corp
F:AV3
|
US |
|
M
|
Mitsubishi Corp
DUS:MBI
|
JP |
|
S
|
Seagate Technology Holdings PLC
XHAM:847
|
SG |
|
Grupo Aeroportuario del Pacifico SAB de CV
NYSE:PAC
|
MX |
|
S
|
Six Flags Entertainment Corp
SWB:6FE
|
US |
|
Brown-Forman Corp
NYSE:BF.B
|
US |
|
H
|
Hecla Mining Co
SWB:HCL
|
US |
|
D
|
D'Ieteren Group NV
SWB:DJDA
|
BE |
|
T
|
TAG Immobilien AG
XHAM:TEG
|
DE |
|
Vodafone Group PLC
LSE:VOD
|
UK |
|
P
|
Plus Therapeutics Inc
XBER:XMPA
|
US |
Multiples-Based Value
The Multiples-Based Value for 
Celldex Therapeutics Inc (TCE2) under the Base Case is hidden
EUR.
Compared with the current market price of 36.65 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TCE2 Multiples-Based Value
LOCKED
